Cell-based Assay Market Projected to Reach US$ 23 Billion by 2024
by Rahul Rastogi Market Research AnalystAccording to the latest report by IMARC Group, titled “Cell-Based Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the global cell-based assay market reached a value of US$ 14 Billion in 2018. The cell-based assay is an analytical method used to determine the concentration of a substance by observing its effects on living organisms (in vivo) or tissues (in vitro). Unlike biochemical assays, they study intact or fixed cells instead of quantifying cell lysate. They are widely utilized in sub-cellular localization, monitoring environmental pollutants and testing cytotoxicity. Apart from this, they are also employed to evaluate a vast array of biochemical, functional and biological effects including gene activation, cell signaling, cell proliferation, antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), apoptosis and necrosis.
Request Free Sample Report: https://www.imarcgroup.com/cell-based-assays-market/request-sample
Market Trends:
The increasing incidence rates of chronic
diseases like cancer, diabetes and cardiovascular diseases is driving the
demand for cell-based assays. For instance, they are widely used for screening
mutagenesis in chronic myeloid leukemia. Moreover, owing to technological
advancements, they are now widely used for drug discovery and toxicology
studies. The advent 3D cell-based assays is expected to create new growth
opportunities for the market. Apart from this, manufacturers are continually
engaging in research and development (R&D) activities to formulate safer
drugs using this technique, thus further contributing to the market growth. On
account of the aforementioned factors, the global cell-based assay market size
is projected to reach US$ 23 Billion by 2024, exhibiting a CAGR of 8.6% during
2019-2024.
Market Summary:
·
On the basis of the product, the market has
been divided into consumables, instruments, services and software. Amongst
these, consumables represent the most preferred product type.
·
Based on the technology, automated handling
accounts for the majority of the overall market share. Other major segments
include flow cytometry, label-free-detection, high-throughput screening and
others.
·
On the basis of the application, drug
discovery exhibits a clear dominance in the market. Other major application
segments include basic research, ADME studies and predictive toxicology and
others.
·
On the basis of the end user, the market has
been classified into pharmaceutical and biotechnology companies, academic and
government institutions, contract research organizations, and others.
Presently, pharmaceutical and biotechnology companies represent the largest end
user.
·
On the geographical front, the market has
been segregated into North America, Europe, Asia Pacific, Middle East and
Africa, and Latin America. Currently, North America holds the leading position
in the market.
·
The competitive landscape has also been
analyzed in the report with some of the major players being Becton Dickinson,
Danaher Corporation, Thermo Fisher Scientific Inc., General Electric Company, Merck
KGaA, Perkinelmer, Inc., Charles River Laboratories, Inc., Lonza Group Ltd.,
Cell Signaling Technology, Inc., Promega Corporation, Cisbio Bioassays, Cell
Biolabs, Inc., Bio-Rad Laboratories, Inc., Corning, Inc., and Hoffmann-La Roche
Ltd.
Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/cell-based-assays-market
About Us
IMARC Group is a leading market research company that
offers management strategy and market research worldwide. We partner with
clients in all sectors and regions to identify their highest-value
opportunities, address their most critical challenges, and transform their
businesses.
IMARC’s information products include major market,
scientific, economic and technological developments for business leaders in
pharmaceutical, industrial, and high technology organizations. Market forecasts
and industry analysis for biotechnology, advanced materials, pharmaceuticals,
food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 | www.imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia:
+91-120-433-0800, +91-120-433-0800
Linkedin: https://www.linkedin.com/company/imarc-group/
Sponsor Ads
Created on Oct 21st 2019 04:41. Viewed 354 times.